Tactile Systems Technology (TCMD) & Masimo Corporation (MASI) Financial Contrast
Tactile Systems Technology (NASDAQ: TCMD) and Masimo Corporation (NASDAQ:MASI) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitabiliy, valuation and analyst recommendations.
This table compares Tactile Systems Technology and Masimo Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Tactile Systems Technology||2.24%||4.82%||3.28%|
This is a breakdown of recent ratings and recommmendations for Tactile Systems Technology and Masimo Corporation, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Tactile Systems Technology||0||0||4||0||3.00|
Tactile Systems Technology currently has a consensus price target of $22.67, indicating a potential downside of 23.63%. Masimo Corporation has a consensus price target of $96.25, indicating a potential upside of 11.70%. Given Masimo Corporation’s higher probable upside, analysts clearly believe Masimo Corporation is more favorable than Tactile Systems Technology.
Valuation & Earnings
This table compares Tactile Systems Technology and Masimo Corporation’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Tactile Systems Technology||$90.69 million||5.54||$4.01 million||$0.09||329.81|
|Masimo Corporation||$730.06 million||6.13||$182.11 million||$6.14||14.03|
Masimo Corporation has higher revenue and earnings than Tactile Systems Technology. Masimo Corporation is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
34.7% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 84.4% of Masimo Corporation shares are owned by institutional investors. 49.9% of Tactile Systems Technology shares are owned by insiders. Comparatively, 16.6% of Masimo Corporation shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Masimo Corporation beats Tactile Systems Technology on 9 of the 13 factors compared between the two stocks.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.
Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.